GT Biopharma, Inc. (GTBP)
0.478
+0.01
(+1.92%)
USD |
NASDAQ |
Feb 27, 16:00
0.47
-0.01
(-1.67%)
After-Hours: 20:00
GT Biopharma Market Cap : 12.74M for Feb. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 839.49M |
| Lyell Immunopharma, Inc. | 355.39M |
| Geron Corp. | 1.072B |
| Regeneron Pharmaceuticals, Inc. | 82.64B |
| Crinetics Pharmaceuticals, Inc. | 4.213B |
Market Cap Related Metrics
| Price to Book Value | 4.248 |
| Price | 0.478 |
| Earnings Yield | -710.3% |